行肝癌切除术的HBsAg阳性和HBsAg阴性/抗-HBc阳性原发性肝癌患者临床特点对比分析

杨可立; 杨湛; 关玉娟; 应若素; 李剑萍

doi:10.3969/j.issn.1001-5256.2015.06.019

行肝癌切除术的HBsAg阳性和HBsAg阴性/抗-HBc阳性原发性肝癌患者临床特点对比分析

DOI: 10.3969/j.issn.1001-5256.2015.06.019

广州市第八人民医院肝病二科

详细信息

中图分类号: R735.7
计量
- 文章访问数: 1898
- HTML全文浏览量: 17
- PDF下载量: 483
- 被引次数: 0
出版历程
- 出版日期: 2015-06-20

Clinical characteristics of patients with HBs Ag( + ) versus HBs Ag(-) / HBc Ab( + ) primary hepatic carcinoma treated by hepatectomy: a comparative analysis

摘要

摘要:
目的比较分析行肝癌切除术的HBs Ag阳性和HBs Ag阴性/抗-HBc阳性的原发性肝癌患者的临床特点差异。方法收集广州市第八人民医院2009年10月至2014年11月行肝癌切除术后的原发性肝癌患者61例,其中HBs Ag阳性患者43例,HBs Ag阴性/抗-HBc阳性患者18例,比较两组患者性别、年龄、肿瘤病理分化程度、脉管癌栓、肝硬化情况等临床特点。计量资料组间比较采用t检验,计数资料组间比较采用χ2检验,非参资料组间比较采用Mann-Whitney U检验。结果 HBs Ag阳性组和HBs Ag阴性/抗-HBc阳性组发病年龄间差异无统计学意义[（50.77±12.93）岁vs（54.28±9.89）岁,t=-1.031,P>0.05];两组患者发现胆管细胞癌的比率差异无统计学意义（2.3%vs 16.7%,χ2=2.24,P>0.05）;两组患者发现肝硬化的比率差异无统计学意义（62.8%vs 44.4%,χ2=1.746,P>0.05）;两组间AFP水平比较,差异无统计学意义[（3638±7869）ng/ml vs（3577±9628）ng/ml,t=0.02...
- 肝肿瘤 /
- 肝炎表面抗原,乙型 /
- 肝切除术
Abstract:
Objective To explore the differences in clinical characteristics between patients with HBs Ag( +) and HBs Ag(-) / HBc Ab( +) primary hepatic carcinoma( PHC) treated by hepatectomy. Methods Forty- three HBs Ag( +) and 18 HBs Ag(-) /HBc Ab( +)patients who underwent liver resection against PHC from October 2009 to November 2014 in Guangzhou 8th People's Hospital were selected for the study. The clinical data of the subjects,including sex,age,histological differentiation,intravascular tumor thrombi,and hepatic cirrhosis,were compared,using t test for continuous data,chi- square test for categorical data,and Mann- Whitney U test for non- parametric data. Results No significant differences existed between patients with HBs Ag( +) and HBs Ag(-) / HBc Ab( +) PHC in terms of the age of onset( 50. 77 ± 12. 93 years vs 54. 28 ± 9. 89 years,t =- 1. 031,P > 0. 05),the incidence of cholangiocarcinoma( 2. 3% vs16. 7%,χ2= 2. 24,P > 0. 05),the incidence of hepatic cirrhosis( 62. 8% vs 44. 4%,χ2= 1. 746,P > 0. 05),alpha- fetoprotein level( 3638 ± 7869 ng/ml vs 3577 ± 9628 ng/ml,t = 0. 026,P > 0. 05),histological differentiation( Z =- 1. 085,P > 0. 05),and the rate of intravascular tumor thrombi( 34. 9% vs 22. 2%,χ2= 0. 949,P > 0. 05). Conclusion There are no significant differences in the age of onset and progression of disease between patients with HBs Ag( +) and HBs Ag(-) / HBc Ab( +) PHC treated by hepatectomy. However,given the possibility of occult hepatitis B virus infection,it is necessary to monitor hepatic carcinoma even post HBs Ag seroconversion
- liver neoplasms /
- hepatitis B surface antigens /
- hepatectomy

HTML全文

参考文献(12)

[1]JI CX,HU JD,XING LJ,et al.Research on pathogenetic mechanism of chronic hepatitis B[J].J Clin Hepatol,2012,28(2):149-152,160.(in Chinese)纪翠霞,胡九东,邢练军,等.乙型肝炎慢性化机制发热研究进[J].临床肝胆病杂志,2012,28(2):149-152,160.

[2]CHEN JG.Trends in the incidence of liver cancer and its primary prevention in China[J].J Clin Hepatol,2012,28(4):256-260.(in Chinese)陈建国.中国肝癌发病趋势和一级预防[J].临床肝胆病杂志,2012,28(4):256-260.

[3]Chinese Expert Consensus Statement Chinese Society of Liver Cancer(CSLC),Chinese Society of Clinical Oncology(CSCO),Liver Cancer Group,Chinese Society of Hepatology.Consensus on standardized diagnosis and treatment of primary liver cancer[J].J Clin Hepatol,2009,25(2):83-92.(in Chinese)中国抗癌协会肝癌专业委员会,中国抗癌协会临床肿瘤学协作专业委员会,中华医学会肝病学分会肝癌学组.原发性肝癌规范化诊治的专家共识[J].临床肝胆病杂志,2009,25(2):83-92.

[4]SU HY,LIU J,HE M,et al.Risk analysis of hepatocellular carcinoma in people with hepatitis B virus infection[J].Chin J Cancer Prev Treat,2008,15(18):1368-1370.(in Chinese)苏洪英,刘静,何苗,等.乙型肝炎病毒感染与原发性肝癌相关的危险度分析[J].中华肿瘤防治杂志,2008,15(18):1368-1370.

[5]GAO HF,TU H.Identification of hepatitis B virus integration sites in hepatocellular carcinomas[J].Chin J Hepatol,2004,12(9):567-568.(in Chinese)高海峰,屠红.肝癌中乙型肝炎病毒整合位点的分离鉴定[J].中华肝脏病杂志,2004,12(9):567-568.

[6]YAN J,YAO ZC,DENG MH.Molecular mechanism in HBV infection related hepatocellular carcinoma[J/CD].Chin Arch General Surg:Electronic Version,2012,6(5):434-438.(in Chinese)颜见,姚志成,邓美海.乙型肝炎病毒相关性肝癌发生的分子机制研究进展[J/CD].中华普通外科学文献:电子版,2012,6(5):434-438.

[7]TSENG TC,LIU CJ,YANG HC,et al.High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load[J].Gastroenterology,2012,142(5):1140-1149.

[8]QU LS,LIU JX,ZHANG HF,et al.Effect of serum hepatitis B surface antigen levels on predicting the clinical outcomes of chronic hepatitis B infection:a meta-analysis[J].Hepatol Res,2014.[Epub ahead of print]

[9]LIU WR,TIAN MX,JIN L,et al.High levels of hepatitis B surface antigen are associated with poorer survival and early recurrence of hepatocellular carcinoma in patients with low hepatitis B viral loads[J].Ann Surg Oncol,2015,22(3):843-850.

[10]CHEN L,ZHAO H,YANG X,et al.HBs Ag-negative hepatitis B virus infection and hepatocellular carcinoma[J].Discov Med,2014,18(99):189-193.

[11]CHEN CY,ZHU XY,ZHOU YA,et al.Study on the molecular mechanism of hepatitis B virus occult infection[J].Inter J Epidemiol Infect Dis,2006,33(4):229-231,264.(in Chinese)陈常云,朱新宇,周永安,等.乙型肝炎病毒隐匿性感染的分子机制研究[J].国际流行病学传染病学杂志,2006,33(4):229-231,264.

[12]KIM GA,LEE HC,KIM MJ,et al.Incidence of hepatocellular carcinoma after HBs Ag seroclearance in chronic hepatitis B patients:a need for surveillance[J].J Hepatol,2014.[Epub ahead of print]

施引文献

资源附件(0)

访问统计